Cited by 162Fibroblast Growth Factor ResearchNeurotransmitter Receptor Influence on BehaviorTreatment of Major Depression

The Fibroblast Growth Factor Family: Neuromodulation of Affective Behavior

Open access
Turner, Cortney A., Watson, Stanley J., Akil, Huda·2012·Neuron

Abstract

In this review, we propose a broader view of the role of the fibroblast growth factor (FGF) family in modulating brain function. We suggest that some of the FGF ligands together with the FGF receptors are altered in individuals with affective disorder and modulate emotionality in animal models. Thus, we propose that members of the FGF family may be genetic predisposing factors for anxiety, depression, or substance abuse; that they play a key organizing role during early development but continue to play a central role in neuroplasticity in adulthood; and that they work not only over extended time frames, but also via rapid signaling mechanisms, allowing them to exert an "on-line" influence on behavior. Therefore, the FGF family appears to be a prototype of "switch genes" that are endowed with organizational and modulatory properties across the lifespan, and that may represent molecular candidates as biomarkers and treatment targets for affective and addictive disorders.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.neuron.2012.08.037

Cites

158 of 158 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • FGF1 and FGF2 bind all four receptor subtypes to activate PLC-γ1 MAPK and AKT pathways.

    “They can bind all four receptor subtypes in order to activate the phospholipase C-γ (PLC-γ1 MAPK and AKT pathways (Turner et al. 2006; Turner et al. 2012).”

    From Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression (2018) · cites this paper as Turner et al. 2012

    The Overview of the FGF Family (page unavailable) says FGF receptors signal primarily through PLCγ, MAPK, and AKT. The FGF Receptors section says many ligands activate one or more of four receptors, but does not say that FGF1 and FGF2 each bind all four. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • FGF1 and FGF2 are dysregulated in mood disorders.

    “FGF1 and FGF2 are the most studied ligands of this family and have been shown to be dysregulated in mood disorders (Turner et al. 2006; Turner et al. 2012).”

    From Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression (2018) · cites this paper as Turner et al. 2012

    The review’s “Why Link the FGF System to Mood and Affect?” section reports that FGF1 and FGF2 were downregulated in brain regions of patients with major depressive disorder (page unavailable). Its “FGF System in Human Studies” section says the FGF family was not altered in the bipolar-disorder subjects studied, so the broader wording “mood disorders” needs qualification. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

1 of the 159 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Turner, C. A., Watson, S. J., & Akil, H.
Affiliations
University of Michigan (US)
Corresponding author
Turner, Cortney A.
Venue
Neuron
Publisher
Elsevier BV
Published
2012-10
Volume
76
Issue
1
Pages
160-174
ISSN
0896-6273 (ISSN-L)
OpenAlex
W2063710526
Cited by
160
References
159
Citations by year
2026: 10 · 2025: 4 · 2024: 7 · 2023: 9 · 2022: 10 · 2021: 10 · 2020: 14 · 2019: 12 · 2018: 12 · 2017: 17 · 2016: 12 · 2015: 11 · 2014: 18 · 2013: 13 · 2012: 1
FWCI
1.25
Type
journal article
Language
en
Open access
Locations
  • Neuron (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Hope for Depression Research Foundation
  • University of Michigan
  • National Institute of Mental Health (P50MH60398, P50MH060398, P01MH042251)
  • National Institute on Drug Abuse (P01DA021633, T32DA007268, R01DA013386)
  • National Center for Research Resources (UL1RR024986)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
Keywords
fibroblast growth factor family, fibroblast growth factor receptor, mood disorders, anxiety, depression, substance abuse, emotionality, neuroplasticity, brain development, switch genes, biomarkers, treatment goals
MeSH terms
Animals, Brain, Fibroblast Growth Factors, Humans, Neurotransmitter Agents, Mood Disorders, Genetic Predisposition to Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review